| Real Estate Management & Development Industry | Real Estate Sector | Mr. Heng Fai Chan CEO | SGX Exchange | - ISIN |
| Singapore Country | - Employees | - Last Dividend | 4 Nov 2014 Last Split | - IPO Date |
Alset International Limited, originally known as Singapore eDevelopment Limited until its rebranding in September 2020, operates as an investment holding entity with a diverse portfolio that spans across several countries including Singapore, South Korea, Australia, and the United States. The company’s activities are broadly categorized into property development and investment, alongside ventures in information technology, biomedical research, and the food and beverage industry. A notable aspect of Alset International is its subsidiary structure, with Alset Business Development Pte. Ltd. serving as a key component of its operational model. This expansive approach allows the company to engage in a wide range of sectors, leveraging cross-industry expertise to foster growth and innovation. Incorporated in 2009, Alset International has established a significant presence in its mainstay markets, reflecting a strategic commitment to diversification and global expansion.
Alset International engages in developing property projects as well as investing in various property development ventures. This dual strategy enables the company to capitalize on the lucrative opportunities within the real estate sectors of its operational countries, seeking to maximize returns on investments through both direct development projects and strategic partnerships.
Through its IT division, the company undertakes the research and development of both hardware and software solutions. It provides a broad array of IT-related services aimed at end-users, service providers, and commercial entities via multiple platforms, entering the bustling e-commerce sector as well.
Alset International’s investment arm deals with trading in quoted securities, commodities, other derivatives, and financial products. It also invests in a diversified portfolio of quoted and unquoted securities, encompassing pre-IPO investments, various forms of company capital, and business growth funds, in addition to engaging in incubation and angel investment activities.
The pursuit of innovation in healthcare is exemplified by the company's involvement in the biomedical sector. It commits resources to the research, development, testing, manufacturing, licensing, and distribution of biomedical products, aiming to contribute valuable advancements and solutions in medical science.
Alset International marks its footprint in the consumer sector through the sale and marketing of food and beverage products. This segment represents the company’s venture into a more consumer-oriented approach, diversifying its investment in real estate and technology with tangible products for everyday consumers.
Expanding its reach beyond tangible goods and property investments, Alset International offers expert consulting services. This encompasses advice on corporate strategy and business development, providing a comprehensive suite of services for companies looking to navigate the complexities of modern business environments.